{
  "drug_name": "Methotrexate_toxicity",
  "url": "https://wikem.org/wiki/Methotrexate_toxicity",
  "scraped_at": "2026-01-10T07:57:19.872137",
  "sections": {
    "Background": {
      "text": "Methotrexate\nblocks dihydrofolate reductase (DHFR) → blocks conversion of folate to folinic acid\nUsed in treatment of\nNon-Hodgkin's lymphoma\n,\nacute lymphocytic leukemia\n, certain other malignancies,\npsoriasis\nand other dermatological conditions,\nrheumatoid arthritis\n(as a DMARD)\nFolate\nsupplementation is often given with methotrexate, and ↓ risk of toxicity\n[1]\nAbsorbed by saturable transporter in GI tract\n[2]\nSingle large oral dose will have lower bioavailability/toxicity than multiple small doses or chronic toxicity.",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Methotrexate",
          "url": "https://wikem.org/wiki/Methotrexate"
        },
        {
          "text": "Non-Hodgkin's lymphoma",
          "url": "https://wikem.org/wiki/Non-Hodgkin%27s_lymphoma"
        },
        {
          "text": "acute lymphocytic leukemia",
          "url": "https://wikem.org/wiki/Acute_lymphocytic_leukemia"
        },
        {
          "text": "psoriasis",
          "url": "https://wikem.org/wiki/Psoriasis"
        },
        {
          "text": "rheumatoid arthritis",
          "url": "https://wikem.org/wiki/Rheumatoid_arthritis"
        },
        {
          "text": "Folate",
          "url": "https://wikem.org/wiki/Folate"
        }
      ]
    },
    "Clinical_Features": {
      "text": "Nausea/vomiting\nFolate deficiency\nMyelosuppression,\npancytopenia\nHepatotoxicity\nAcutely - transaminitis\nChronic -\ncirrhosis\n/fibrosis\nPulmonary toxicity\nRenal injury\n(ATN) secondary to precipitation of methotrexate crystals\n[2]\nCutaneous injury (stomatitis, mucositis, ulcerations,\nSJS\nand\nTEN\n, etc.)",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Nausea/vomiting",
          "url": "https://wikem.org/wiki/Nausea/vomiting"
        },
        {
          "text": "Folate deficiency",
          "url": "https://wikem.org/wiki/Folate_deficiency"
        },
        {
          "text": "pancytopenia",
          "url": "https://wikem.org/wiki/Pancytopenia"
        },
        {
          "text": "Hepatotoxicity",
          "url": "https://wikem.org/wiki/Hepatotoxicity"
        },
        {
          "text": "cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        },
        {
          "text": "Renal injury",
          "url": "https://wikem.org/wiki/Acute_kidney_injury"
        },
        {
          "text": "SJS",
          "url": "https://wikem.org/wiki/SJS"
        },
        {
          "text": "TEN",
          "url": "https://wikem.org/wiki/TEN"
        }
      ]
    },
    "Management": {
      "text": "Early initiation of therapy is important, so begin treatment once MTX toxicity is strongly suspected\nFolinic Acid (\nLeucovorin\n)\n[1]\n20mg IV or IM q6h until MTX serum level <10\n−8\nM\nGlucarpidase\nWorks by enzymatic cleaving of MTX into metabolites\nHydration and urine alkalinization\nBicarbonate\ndrip at 1.5-2x maintenance rate to maintain urine pH of >7.5\nMTX is excreted renally",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Leucovorin",
          "url": "https://wikem.org/wiki/Leucovorin"
        },
        {
          "text": "Glucarpidase",
          "url": "https://wikem.org/wiki/Glucarpidase"
        },
        {
          "text": "Bicarbonate",
          "url": "https://wikem.org/wiki/Bicarbonate"
        }
      ]
    },
    "Disposition": {
      "text": "Admit",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}